Liao Huocheng, Li Zhiming, Zheng Dongdan, Liu Jianping, Liu Yan, Xiao Chun, Wang Hongguang
Internal Medicine-Cardiovascular Department, Dongying People's Hospital of Shandong Province, NO,137, Nanyi Road, Dongying, Shangdong Province, China.
Lipids Health Dis. 2014 Jul 29;13:120. doi: 10.1186/1476-511X-13-120.
High sensitivity C-reactive protein (Hs-CRP) and adiponectin (APN) are two critical cytokines and exert inverse effects on atherosclerosis initiation and progression. The purpose of our study was to investigate the value of Hs-CRP and ANP ratio (Hs-CRP/APN ratio) on evaluating atherosclerosis progression.
One hundred sixty consecutive participants underwent carotid intima-media thickness (CIMT) measured by ultrasound were enrolled and drawn fasting blood samples for plasma levels Hs-CRP and APN, serum levels of lipid profiles and fasting blood glucose evaluation. Other anthropometrics and clinical status were collected by questionnaire. All participants were divided into 4 groups according to the baseline Hs-CRP/APN ratio and underwent CIMT measurement every 6 months. CIMT increment and composite cardiovascular endpoints were compared after 24 months' follow-up.
At baseline, body mass index (BMI), smoking, diabetic mellitus, usage of statins, Hs-CRP and APN independently correlated with Hs-CRP/APN ratio as analyzed by spearman rank correlation. Smoking, serum level of LDL-C, plasma level of Hs-CRP and Hs-CRP/APN ratio were positively correlated with CIMT while usage of statins and plasma level of APN were negatively correlated with CIMT as analyzed by multiple linear regression analysis. After 24 months' follow-up, the progression of CIMT was the most prominent in the fourth quartile of baseline Hs-CRP/APN ratio. In addition, the incidence of composite cardiovascular endpoint was also higher in the fourth quartile as compared to the other 3 lower quartiles.
Hs-CRP/APN ratio was a useful predictor to discriminate subjects who were at increased risk of atherosclerosis progression.
高敏C反应蛋白(Hs-CRP)和脂联素(APN)是两种关键的细胞因子,对动脉粥样硬化的起始和进展具有相反的作用。我们研究的目的是探讨Hs-CRP与APN比值(Hs-CRP/APN比值)在评估动脉粥样硬化进展中的价值。
连续纳入160名接受超声测量颈动脉内膜中层厚度(CIMT)的参与者,并采集空腹血样以检测血浆Hs-CRP和APN水平、血脂谱血清水平及空腹血糖。通过问卷调查收集其他人体测量学和临床状况信息。所有参与者根据基线Hs-CRP/APN比值分为4组,每6个月进行一次CIMT测量。随访24个月后比较CIMT增量和复合心血管终点。
在基线时,经Spearman等级相关分析,体重指数(BMI)、吸烟、糖尿病、他汀类药物使用情况、Hs-CRP和APN与Hs-CRP/APN比值独立相关。经多元线性回归分析,吸烟、低密度脂蛋白胆固醇(LDL-C)血清水平、Hs-CRP血浆水平和Hs-CRP/APN比值与CIMT呈正相关,而他汀类药物使用情况和APN血浆水平与CIMT呈负相关。随访24个月后,基线Hs-CRP/APN比值第四四分位数组的CIMT进展最为显著。此外,与其他3个较低四分位数组相比,第四四分位数组的复合心血管终点发生率也更高。
Hs-CRP/APN比值是鉴别动脉粥样硬化进展风险增加受试者的有用预测指标。